Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillance.
about
Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.HPV catch-up vaccination of young women: a systematic review and meta-analysis.Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84--results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany.Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing.Correlation of cervical smear and pathohistological findingsHuman papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational studyOptimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in AustraliaRisk of Delayed Human Papillomavirus Vaccination in Inner-City Adolescent Women.Reply to Ryser et al.Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: Observational cohort of young women in Australia.
P2860
Q30251868-04D84B58-ECF3-4EBA-B88E-1124CCF0FA19Q30682187-A172BE83-53DF-4F15-9EC7-F78FED8BC6CFQ34157209-26E0EB16-8351-409C-8EA5-27AE0A8DBDD7Q34622565-BEB5C49A-103D-46BB-9D9D-26EAC072C367Q34736619-8317AA73-5047-4404-884D-4DDB294E05A3Q34746231-D8D194F9-F1B0-4FC8-8A58-7685B9B6CA07Q34987731-744EC121-77ED-4968-B8FA-8DD0DA51F3BCQ36251151-6C8C97D2-F4DB-471C-A971-B847CD00EDC7Q40412473-1F5FD77E-04B8-4DB1-80FC-1AE3E7C4CE59Q44701708-B837E863-A594-479F-97CF-4D0B3C42518EQ55262571-526BFA88-A8BD-43BB-A706-C4348B50C891
P2860
Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillance.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Does HPV type 16 or 18 prevale ...... postvaccination surveillance.
@en
Does HPV type 16 or 18 prevale ...... postvaccination surveillance.
@nl
type
label
Does HPV type 16 or 18 prevale ...... postvaccination surveillance.
@en
Does HPV type 16 or 18 prevale ...... postvaccination surveillance.
@nl
prefLabel
Does HPV type 16 or 18 prevale ...... postvaccination surveillance.
@en
Does HPV type 16 or 18 prevale ...... postvaccination surveillance.
@nl
P2860
P356
P1433
P1476
Does HPV type 16 or 18 prevale ...... postvaccination surveillance.
@en
P2093
Sepehr N Tabrizi
Suzanne M Garland
P2860
P304
P356
10.2217/FMB.11.161
P577
2012-02-01T00:00:00Z